Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-α and soluble adhesion molecules

Abstract

This study addressed two questions: first, whether the supranormal adherence of blood lymphocytes from patients with multiple sderosis (MS) to endothelial cell monolayers treated with tumour necrosis factor-α (TNFα) was a feature common to other inflammatory disorders; and second, whether the adherence properties of blood lymphocytes from MS patients were related to changes in disease activity and to levels of circulating TNFα and soluble adhesion molecules. In the first part of the investigation, lymphocytes from I 4 patients with MS were more adherent to TNFα-treated endothelial cells (P < 0.01) than those from healthy controls, whereas the adherence properties of lymphocytes from 12 patients with rheumatoid arthritis, eight patients with psoriasis and ten patients with neurological diseases other than MS were normal. In the second phase of the work, measurement of the adhesive properties of lymphocytes isolated at monthly intervals from a further six MS patients over a 5 - 8 month period, found that changes in binding to TNFα-treated endothelial cells, directly paralleled changes in circulating levels of TNFα (r =0.77; P < 0.001) and soluble vascular cell adhesion molecule-I (sVCAM-I) (r=0.67; P=0.001). An increase in disease activity, measured by T2-weighted and gadolinium-enhanced magnetic resonance imaging of the central nervous system (CNS), occurred in two patients and was associated with heightened lymphocyte adhesiveness and a rise in serum TNFα levels. Further analysis of the 34 serum samples from the six MS patients revealed a direct relationship between the concentration of sL-selectin and soluble intercellular adhesion molecule- (sICAM-I) (r=0.65; P < 0.001) and between sL-selectin and sTNFα (r=0.42; P < 0.02). These findings support the view that disease activity in MS is associated with an increased adhesive interaction of blood lymphocytes with vascular endothelium at inflammatory sites within the CNS.

Keywords

adherence disease activity endothelial cells lymphocytes multiple sclerosis tumour necrosis factor

Get full access to this article

View all access options for this article.

References

Martin R. (1992) Immunological aspects of demyelinating diseases . Ann Rev Immunol 10: 153 -187.

Raine CS (1994) The Dale E McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 36: S61-S72.

Cross AH , Cannella B. , Brosnan CF , Raine CS (1993) Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J Neuroimmunol 33: 237-244.

Wekerle H. (1993) Lymphocyte traffic to the brain. In: Pardridge WM (ed.). The Blood-Brain Barrier . Raven Press, New York: pp 67-85.

Bevilacqua MP (1993) Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 11: 767-804.

Sobel RA , Mitchell ME , Fondren G. (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136: 1309-1316.

Dore-Duffy P. , Washington R. , Dragovic L. (1993) Expression of endothelial cell activation antigens in micro-vessels from patients with multiple sclerosis. In: Drewes LR , Bets AL (eds.). Frontiers in Cerebral Vascular Biology: Transport and its Regulation. Plenum Press: pp 243-248.

Wilcox CE et al. (1990) Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis . J Neuroimmunol 30: 43 - 51.

Cannella B. , Cross AH , Raine CS (1991) Relapsing autoimmune demyelination: a role for vascular addressins. J Neuroimmunol 35: 295-300.

10.

Fabry Z. et al. (1992) Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp55. J Neuroimmunol 36: 1-11.

11.

Wong D. , Dorovini-Zis K. (1995) Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvascular Research 49: 325-339.

12.

McCarron RM et al. (1993) Cytokine regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol 43: 23 - 30.

13.

Hofman FM , Hilton DR , Johnson K. , Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607 - 612.

14.

Selmaj J. , Raine CS , Cannella B. , Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-954.

15.

Simmons RD , Willenborg DO (1990) Direct injections of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neurol Sci 100: 37-42.

16.

Sharief MK , Hentges R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Eng J Med 325: 467-470.

17.

Tsukuda N. , Miyagi K. , Matsuda M. , Yanagisawa N. (1993) Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphocyte virus-1 associated myelopathy. Ann Neurol 33: 646-649.

18.

Droogan AG , McMillan SA , Douglas JP , Hawkin SA (1996) Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J Neuroimmunol 64: 185-191.

19.

Vora AJ et al. (1996) Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha (TNF-α)-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expression. Clin Exp Immunol 105: 155-162.

20.

McDonald WI , Halliday AM (1977) Diagnosis and classification of multiple sclerosis. Brit Med Bull 33: 4-9.

21.

Poser CM (1986) Pathogenesis of multiple sclerosis. Acta Neuropathol 71: 1-10.

22.

Brown KA et al. (1993) Application of an immortalized human endothelial cell line to the leucocyte:endothelial adherence assay. J Immunol Methods 163: 13 - 22.

23.

Brinkman CJ et al. (1982) T-lymphocyte subpopulations in multiple sclerosis lesions. N Eng J Med 307: 1644.

24.

Nyland H. et al. (1982) T-lymphocyte subpopulations in multiple sclerosis lesions. N Eng J Med 307: 1643-1644.

25.

Hafler DA , Weiner HL (1987) T cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol Reviews 100: 307-332.

26.

Hawkins CP , Munro Pmg , Mackenzie F. (1990) Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied using gadolinium-DTPA and protein markers. Brain 113: 365-378.

27.

Katz D. et al. (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34: 661-669.

28.

Cannella B. , Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37: 424-435.

29.

Cannella B. , Cross AH , Raine CS (1990) Upregulation and co-expression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 172: 1521-1524.

30.

Powell MB et al. (1990) Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 2: 539-544.

31.

Kuroda Y. , Shimamoto Y. (1991) Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J Neuroimmunol 34: 159-164.

32.

Ruddle NH et al. (1990) An antibody to lymphotoxin and tumour necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193-1200.

33.

Cronstein BN , Weissmann G. (1993) The adhesion molecules of inflammation. Arthr Rheum 36: 147-157.

34.

Carrieri PB et al. (1992) Cytokines in the pathogenesis of multiple sclerosis. Acta Neurologica 14: 333-341.

35.

Oger J. , Kastrukoff LF , Li Dkb , Paty WP ( 1988) Multiple sclerosis: in relapsing patients immune functions vary with disease activity as assessed by MRI. Neurology 38: 1739-1744.

36.

Bellamy AS , Calder VL , Feldmann M. , Davison AN (1985) The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes . Clin Exp Immunol 61: 248-256.

37.

Hafler DA et al. (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Eng J Med 312: 1405 -1411.

38.

Porrini AM , Gambi D. , Malatesta G. (1992) Memory and naive CD4+lymphocytes in multiple sclerosis . J Neurol 239: 437-440.

39.

Svenningsson A. et al. (1993) Adhesion molecule expression on cerebospinal fluid T-lymphocytes: evidence for common recruitment mechanism in multiple sclerosis, aspetic meningitis and normal controls. Ann Neurol 34: 155-161.

40.

Stüber A. et al. (1996) Expression pattern of activation and adhesion molecules on peripheral blood CD4+T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis. J Neuroimmunol 66: 147-151.

41.

Jung TM , Gallatin WM , Weissman IL , Dailey MO (1988) Down-regulation of homing receptors after T cell activation. J Immunol 141: 4110-4117.

42.

Tedder TF (1991) Cell-surface receptor shedding: a means of regulating function. Am J Respir Cell Mol Biol 5: 305-306.

43.

Schleiffenbaum B. , Spertini O. , Tedder TF (1992) Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 199: 229-238.

44.

Möbner R. et al. (1996) Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques. J Neuroimmunol 65: 61-65.

45.

Rieckmann P. et al. (1993) Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol 47: 133-140.

46.

Hartung H-P et al. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45: S22-S32.